A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

In this op-ed, Erin Core, managing director, Veracity Research explores the price paid for attention in a short form content ...

According to new research, this centuries-old beverage supports long-term brain health by dialing down inflammation and ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Of the large percentage of antidepressant takers who experience sexual side effects, there is a small percentage for ... many people opt for or switch to bupropion, a norepinephrine-dopamine reuptake ...

Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...

With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

Brandi Carlile talks about her new album, 'Returning to Myself,' and the reaction she got when she first played the song ...

NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...

Jean Smith, whose name has been changed to protect her privacy, began to experience symptoms of what she later learned was restless legs syndrome (RLS) when she was 29 years old and pregnant.

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...